Arikan, Ayse Akcan <br/><br/>
Interleukin-6 treatment reverses apoptosis and blunts susceptibility to intraperitoneal bacterial challenge following hemorrhagic shock.  [electronic resource] 

 -  Critical care medicine  Mar 2006 
 - 771-7 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0090-3493 
<br/><br/><label>Standard No.: </label>10.1097/01.ccm.0000201901.30292.c2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Colony Count, Microbial<br/>Cross Infection--physiopathology<br/>Disease Susceptibility<br/>Inflammation--prevention & control<br/>Interleukin-6--pharmacology<br/>Liver--cytology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Random Allocation<br/>Recombinant Proteins<br/>Resuscitation<br/>Sepsis--physiopathology<br/>Shock, Hemorrhagic--drug therapy